PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 67 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,285,892 | -53.6% | 316,900 | -23.1% | 0.01% | -51.7% |
| Q2 2023 | $11,382,202 | +10.0% | 412,100 | -8.4% | 0.03% | +7.4% |
| Q1 2023 | $10,345,400 | +57.1% | 449,800 | -25.5% | 0.03% | +50.0% |
| Q4 2022 | $6,584,185 | +91.7% | 603,500 | +48.2% | 0.02% | +80.0% |
| Q3 2022 | $3,434,000 | -16.3% | 407,300 | -21.4% | 0.01% | -16.7% |
| Q2 2022 | $4,101,000 | -19.3% | 518,400 | +141.5% | 0.01% | -14.3% |
| Q1 2022 | $5,084,000 | +283.1% | 214,700 | +453.4% | 0.01% | +366.7% |
| Q4 2021 | $1,327,000 | -48.5% | 38,800 | -73.3% | 0.00% | -57.1% |
| Q3 2021 | $2,575,000 | -77.6% | 145,300 | -43.3% | 0.01% | -76.7% |
| Q2 2021 | $11,493,000 | +28.0% | 256,075 | -26.1% | 0.03% | +20.0% |
| Q1 2021 | $8,979,000 | +21.3% | 346,675 | -5.6% | 0.02% | +25.0% |
| Q4 2020 | $7,404,000 | +6.6% | 367,275 | +3.4% | 0.02% | 0.0% |
| Q3 2020 | $6,944,000 | -6.2% | 355,175 | -15.3% | 0.02% | -9.1% |
| Q2 2020 | $7,403,000 | +366.8% | 419,200 | +86.6% | 0.02% | +266.7% |
| Q1 2020 | $1,586,000 | -29.5% | 224,700 | -29.6% | 0.01% | +20.0% |
| Q4 2019 | $2,249,000 | +23.0% | 319,000 | +109.6% | 0.01% | +25.0% |
| Q3 2019 | $1,828,000 | +20.7% | 152,200 | +21.8% | 0.00% | 0.0% |
| Q2 2019 | $1,514,000 | +28.4% | 125,000 | +33.3% | 0.00% | +33.3% |
| Q1 2019 | $1,179,000 | +82.2% | 93,800 | -2.5% | 0.00% | +50.0% |
| Q4 2018 | $647,000 | -56.0% | 96,200 | -32.8% | 0.00% | -50.0% |
| Q3 2018 | $1,472,000 | +38.7% | 143,100 | -9.4% | 0.00% | +33.3% |
| Q2 2018 | $1,061,000 | +162.0% | 157,900 | +235.2% | 0.00% | +200.0% |
| Q1 2018 | $405,000 | +11.9% | 47,100 | +170.7% | 0.00% | 0.0% |
| Q4 2017 | $362,000 | – | 17,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $26,721 | 7.77% |
| Bain Capital Life Sciences Investors, LLC | 2,364,410 | $25,796 | 2.88% |
| Sio Capital Management, LLC | 434,635 | $4,741,868 | 1.75% |
| Tri Locum Partners LP | 199,500 | $2,177,000 | 0.88% |
| Kynam Capital Management, LP | 520,922 | $5,683,259 | 0.87% |
| RTW INVESTMENTS, LP | 3,591,986 | $39,188,567 | 0.80% |
| Madison Avenue Partners, LP | 406,593 | $4,435,930 | 0.79% |
| Deep Track Capital, LP | 871,493 | $9,507,989 | 0.40% |
| Soleus Capital Management, L.P. | 236,000 | $2,574,760 | 0.37% |
| BRAIDWELL LP | 927,800 | $10,122,298 | 0.34% |